PubRank
Search
About
Samantha Bosis
Author PubWeight™ 30.27
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years.
Vaccine
2005
2.04
2
Role of atypical bacteria and azithromycin therapy for children with recurrent respiratory tract infections.
Pediatr Infect Dis J
2005
1.47
3
Impact of human coronavirus infections in otherwise healthy children who attended an emergency department.
J Med Virol
2006
1.31
4
Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households.
Vaccine
2003
1.25
5
Comparison of nasopharyngeal nylon flocked swabs with universal transport medium and rayon-bud swabs with a sponge reservoir of viral transport medium in the diagnosis of paediatric influenza.
J Med Microbiol
2010
1.22
6
Influenza vaccination among healthcare workers in a multidisciplinary University hospital in Italy.
BMC Public Health
2008
1.11
7
Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants.
Vaccine
2005
1.07
8
Impact of human bocavirus on children and their families.
J Clin Microbiol
2008
1.04
9
Evaluation of a rapid bedside test for the quantitative determination of C-reactive protein.
Clin Chem Lab Med
2005
1.04
10
Cytokine secretion in children with acute Mycoplasma pneumoniae infection and wheeze.
Pediatr Pulmonol
2002
1.02
11
Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia.
Respir Med
2011
1.00
12
Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention.
Vaccine
2007
0.98
13
Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2-5 years of age with community-acquired pneumonia.
Clin Infect Dis
2002
0.97
14
Influenza vaccination coverage among children with high-risk medical conditions.
Vaccine
2006
0.96
15
Aetiology of acute pharyngitis: the role of atypical bacteria.
J Med Microbiol
2004
0.95
16
Use of linezolid in infants and children: a retrospective multicentre study of the Italian Society for Paediatric Infectious Diseases.
J Antimicrob Chemother
2011
0.92
17
Effects of coronavirus infections in children.
Emerg Infect Dis
2010
0.90
18
Evaluation of rapid assay for detection of Streptococcus pneumoniae urinary antigen among infants and young children with possible invasive pneumococcal disease.
Pediatr Infect Dis J
2004
0.89
19
Recommendations for the use of influenza vaccine in pediatrics.
Hum Vaccin Immunother
2012
0.88
20
Borrelia burgdorferi infection and Lyme disease in children.
Int J Infect Dis
2012
0.87
21
A case of meningitis due to varicella zoster virus reactivation in an immunocompetent child.
Ital J Pediatr
2013
0.86
22
Altered cardiac rhythm in infants with bronchiolitis and respiratory syncytial virus infection.
BMC Infect Dis
2010
0.83
23
Long-term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in pre-term infants.
Vaccine
2002
0.81
24
Peritoneal tuberculosis due to multidrug-resistant Mycobacterium tuberculosis.
Pediatr Int
2013
0.79
25
Human metapneumovirus and lower respiratory tract disease in children.
N Engl J Med
2004
0.79
26
Brain abscess due to Streptococcus intermedius in a 3-year-old child.
Pediatr Int
2011
0.77
27
Acute tonsillopharyngitis associated with atypical bacterial infection in children: natural history and impact of macrolide therapy.
Clin Infect Dis
2006
0.76
28
Levofloxacin for the treatment of Mycoplasma pneumoniae-associated meningoencephalitis in childhood.
Int J Antimicrob Agents
2011
0.76
29
Theoretic coverage of heptavalent pneumococcal conjugate vaccine in the prevention of community-acquired pneumonia in children in Italy.
Vaccine
2003
0.76
30
Immunogenicity, safety and tolerability of meningococcal C CRM197 conjugate vaccine administered 3, 5 and 11 months post-natally to pre- and full-term infants.
Vaccine
2007
0.75
31
Efficacy, safety, and tolerability of a 24-month treatment regimen including delamanid in a child with extensively drug-resistant tuberculosis: A case report and review of the literature.
Medicine (Baltimore)
2016
0.75
32
Subcutaneous emphysema as the first relevant clinical sign of complicated tubercular lymph node disease in a child.
BMC Infect Dis
2013
0.75
33
Comparative efficacy and safety of 5-day cefaclor and 10-day amoxycillin treatment of group A streptococcal pharyngitis in children.
Int J Antimicrob Agents
2002
0.75